SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Tygoshura Bragore
Country: Oman
Language: English (Spanish)
Genre: Technology
Published (Last): 27 September 2009
Pages: 206
PDF File Size: 19.75 Mb
ePub File Size: 2.90 Mb
ISBN: 199-9-41233-783-5
Downloads: 71078
Price: Free* [*Free Regsitration Required]
Uploader: Meztizilkree

The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Glycopyrronium. The risk or severity of adverse effects can be increased when Dosulepin is combined with Glycopyrronium.

Nortriptyline The risk or severity of adverse effects can be increased when Nortriptyline is combined with Glycopyrronium. The therapeutic efficacy of Glycopyrrolqte can be decreased when used in combination with Aprotinin. Bambuterol The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Bambuterol. The risk or severity of adverse effects can be increased when Etanautine is combined with Glycopyrronium. Etanautine The risk or severity of adverse effects can be increased when Etanautine is combined with Glycopyrronium.

Disopyramide The risk or severity of glycopyrrplate effects can be increased when Msde is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Isopropamide is combined with Glycopyrronium. Anagrelide The risk or severity of Tachycardia gglycopyrrolate be increased when Anagrelide is combined with Glycopyrronium.

The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Dopamine. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Morphine. The risk or severity of Tachycardia can be increased when Bitolterol is combined with Glycopyrronium.

The risk or severity of Tachycardia mdds be increased when Glycopyrronium is combined with Methoxyphenamine. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with PF The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Dronabinol.

  1988 TOYOTA CAMRY MANUAL PDF

The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Glhcopyrrolate. Ipidacrine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ipidacrine. Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Glycopyrronium. The risk or severity of adverse effects can be glycopyrrolwte when Bevonium is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Etorphine.

Higenamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Higenamine. Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Anisodamine. The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Glycopyrronium. Potassium chloride The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Potassium Chloride.

Amantadine Amantadine may increase the anticholinergic activities of Glycopyrronium. Meptazinol The risk or severity of adverse effects glycopyrrolte be increased when Glycopyrronium is combined with Meptazinol. Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Glycopyrronium.

The risk or severity of adverse effects can be increased when Paroxetine is combined with Glycopyrronium. Diphemanil The risk or severity of adverse effects can be increased when Diphemanil is combined with Glycopyrronium.

Oxymetazoline The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Glycopyrronium. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Paraoxon.

Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Glycopyrronium. Octaethylene glycol The therapeutic efficacy of Octaethylene glycol can be decreased when used in combination with Glycopyrronium. The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Glycopyrronium. Methadone Methadone may increase the anticholinergic activities of Glycopyrronium.

  EGW EVANGELISM PDF

The risk or severity of adverse effects can be increased when Pizotifen is combined with Glycopyrronium. Lisdexamfetamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined msdds Lisdexamfetamine.

Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Glycopyrronium.

Aprotinin The therapeutic msxs of Glycopyrronium can be decreased when used in combination with Aprotinin.

The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Potassium Chloride. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Memantine. Ritodrine The risk or severity of Tachycardia can be increased when Ritodrine is combined with Glycopyrronium.

Glycopyrronium – DrugBank

Cisplatin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Cisplatin. Profenamine The risk or severity of adverse effects can be increased when Ethopropazine is combined with Glycopyrronium. Puromycin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Puromycin. Nicotine The risk or severity of Tachycardia can be increased when Nicotine is combined with Glycopyrronium. Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Glycopyrronium.

Glycopyrronium

Tiotropium The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Tiotropium. Tyramine The risk or severity of Tachycardia can be glycopyrrilate when Glycopyrronium is combined with Tyramine. Oxybutynin The risk or severity of adverse effects can be increased when Oxybutynin is combined with Glycopyrronium. Rivastigmine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.

The risk or severity of Tachycardia can be increased when Phenmetrazine is combined with Glycopyrronium. Glycopyrdolate The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Glycopyrronium.